Piper Sandler Maintains Neutral on Staar Surgical, Lowers Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien has maintained a Neutral rating on Staar Surgical (NASDAQ:STAA) and lowered the price target from $45 to $40.
November 02, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained a Neutral rating on Staar Surgical and lowered the price target from $45 to $40.
The lowering of the price target by Piper Sandler from $45 to $40 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Staar Surgical's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100